BioStone Animal Health Launches CAEV/MVV Antibody Test Kit
DALLAS-FORT WORTH, TX — April 3, 2023 — BioStone Animal Health is pleased to announce the launch of AsurDxTM Caprine Arthritis Encephalitis Virus/Maedi-Visna Virus (CAEV/MVV) Antibody Test Kit for the detection of antibodies specific to Caprine arthritis encephalitis and Maedi-visna virus (CAEV/MVV) in goat and sheep sera and plasma. Caprine arthritis encephalitis (CAE) is a retroviral disease of goats that is primarily transferred through colostrum and milk of infected animals but can also be transmitted in utero or through infected saliva. It affects the host immune system, primarily macrophages and monocytes; a common early sign of infection is weight loss. Other symptoms can include arthritis, pneumonia, indurative mastitis, reduced milk production, and encephalitis. The AsurDxTM Caprine Arthritis Encephalitis Virus/Maedi-Visna Virus (CAEV/MVV) Test Kit provides a simple, rapid, sensitive, and cost-effective enzyme-based immunoassay (ELISA) screening method.
About BioStone Animal Health — BioStone Animal Health is a Dallas, TX-based biotechnology company that provides innovative solutions for animal health. BioStone Animal Health works together with our worldwide partners to offer a portfolio of animal disease diagnostic products as well as test kits and reagents for vaccine testing that enables performing a rapid evaluation of the efficacies, stability, consistency, and potency of common animal vaccines. BioStone strives to actively promote and participate in global animal health initiatives by making these test kits available to the international community. For more information about BioStone Animal Health, visit www.biostoneah.com